首页> 美国卫生研究院文献>Neuropsychiatric Disease and Treatment >Current approaches to treatments for schizophrenia spectrum disorders part I: an overview and medical treatments
【2h】

Current approaches to treatments for schizophrenia spectrum disorders part I: an overview and medical treatments

机译:精神分裂症频谱障碍的当前治疗方法第一部分:概述和药物治疗

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

During the last three decades, an increasing understanding of the etiology, psychopathology, and clinical manifestations of schizophrenia spectrum disorders, in addition to the introduction of second-generation antipsychotics, has optimized the potential for recovery from the illness. Continued development of various models of psychosocial intervention promotes the goal of schizophrenia treatment from one of symptom control and social adaptation to an optimal restoration of functioning and/or recovery. However, it is still questionable whether these new treatment approaches can address the patients’ needs for treatment and services and contribute to better patient outcomes. This article provides an overview of different treatment approaches currently used in schizophrenia spectrum disorders to address complex health problems and a wide range of abnormalities and impairments resulting from the illness. There are different treatment strategies and targets for patients at different stages of the illness, ranging from prophylactic antipsychotics and cognitive–behavioral therapy in the premorbid stage to various psychosocial interventions in addition to antipsychotics for relapse prevention and rehabilitation in the later stages of the illness. The use of antipsychotics alone as the main treatment modality may be limited not only in being unable to tackle the frequently occurring negative symptoms and cognitive impairments but also in producing a wide variety of adverse effects to the body or organ functioning. Because of varied pharmacokinetics and treatment responsiveness across agents, the medication regimen should be determined on an individual basis to ensure an optimal effect in its long-term use. This review also highlights that the recent practice guidelines and standards have recommended that a combination of treatment modalities be adopted to meet the complex health needs of people with schizophrenia spectrum disorders. In view of the heterogeneity of the risk factors and the illness progression of individual patients, the use of multifaceted illness management programs consisting of different combinations of physical, psychological, and social interventions might be efficient and effective in improving recovery.
机译:在过去的三十年中,除了引入第二代抗精神病药外,对精神分裂症谱系疾病的病因,心理病理学和临床表现的了解也不断增加,从而优化了疾病康复的潜力。不断发展的各种心理社会干预模型促进了精神分裂症治疗的目标,从症状控制和社会适应中的一种到功能和/或恢复的最佳恢复。但是,这些新的治疗方法能否满足患者对治疗和服务的需求,并有助于改善患者的结局,仍然值得怀疑。本文概述了目前用于精神分裂症谱系障碍的各种治疗方法,以解决复杂的健康问题以及由疾病引起的各种异常和损害。对于疾病不同阶段的患者,有不同的治疗策略和目标,从病前阶段的预防性抗精神病药和认知行为疗法到各种心理社会干预措施,以及在疾病后期预防和康复的抗精神病药。单独使用抗精神病药作为主要治疗方式不仅可能无法解决常见的不良症状和认知障碍,而且还可能对身体或器官功能产生各种各样的不良影响。由于不同药物的药代动力学和治疗反应性不同,应根据个人情况确定用药方案,以确保长期使用具有最佳效果。这篇评论还强调指出,最近的实践指南和标准建议采用多种治疗方式,以满足精神分裂症谱系疾病患者的复杂健康需求。鉴于风险因素的异质性和个别患者的疾病进展,使用由身体,心理和社会干预措施的不同组合组成的多方面疾病管理计划可能会有效提高恢复效率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号